InvestorsHub Logo
Followers 826
Posts 119569
Boards Moderated 14
Alias Born 09/05/2002

Re: None

Wednesday, 02/14/2018 8:23:29 AM

Wednesday, February 14, 2018 8:23:29 AM

Post# of 625
ICPT’s partner dumps Ocaliva for Japanese/Korean markets; this was buried in ICPT’s 4Q17 PR:

https://finance.yahoo.com/news/intercept-pharmaceuticals-reports-full-fourth-120500415.html

In February, Intercept amended its exclusive license agreement with Sumitomo Dainippon to regain the rights to develop and commercialize OCA in Japan and Korea. Under the new terms of the license agreement, Intercept will forego any further milestone or royalty payments for the development and commercialization of OCA in these countries.


“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent ICPT News